Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy including surgery, irradiation, and chemotherapy. It has become clear in recent ...

The agent is currently being evaluated in a phase 1a study, and a phase 1b/2a study will continue to assess LP-184’s safety ...

Glioblastoma is the most common – and the most malignant – primary brain tumour in adults. It's aggressive and incurable.

Glioblastomas are aggressive brain tumors with a median survival time of less than 22 months despite standard therapy ...

Glioblastoma, a rare but devastating form of brain cancer, has long been considered virtually incurable. With a grim ...

Glioblastoma is the most common and aggressive type of primary brain tumor, with an average survival rate of 15 months, ...

In a small but important Phase 1 study, MTX110 is outperforming historic norms of progression free and overall survival ...

Liam Payne was 'one of the kindest souls,' the wife of the late The Wanted singer Tom Parker said in an emotional post following the former One Direction singer's death at age 31 ...

A BREAKTHROUGH cancer treatment “could be the cure” for a “death sentence” form of the disease after making tumours disappear ...

A woman from Wilmington is putting her faith in the GammaTile procedure as the first patient to undergo the treatment at ...

Noreen Baker died on Sept. 25, 2024, of glioblastoma. She lived for nearly four years with a disease with an average life expectancy of 15 months, a testament to her unrelenting optimism. Noreen ...

A recent study has revealed that chloride flow through channels on the surface of tumor cell lines plays a crucial role in ...